Vaxcyte, Inc.
PCVX
$44.70
-$0.82-1.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.71B | 1.66B | 1.67B | 1.75B | 2.18B |
| Total Receivables | 400.00K | 100.00K | -- | 20.66M | 17.87M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 55.45M | 54.25M | 44.83M | 15.73M | 10.59M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 4.38M | 4.94M |
| Total Current Assets | 1.77B | 1.72B | 1.72B | 1.79B | 2.21B |
|
|
|||||
| Total Current Assets | 1.77B | 1.72B | 1.72B | 1.79B | 2.21B |
| Net Property, Plant & Equipment | 337.00M | 327.92M | 304.91M | 270.15M | 191.94M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 108.18M | 96.58M | 77.60M | 65.68M | 61.36M |
| Total Assets | 3.17B | 3.31B | 3.38B | 3.51B | 3.56B |
|
|
|||||
| Total Accounts Payable | 48.96M | 31.41M | 20.51M | 48.45M | 18.22M |
| Total Accrued Expenses | 145.31M | 116.77M | 70.35M | 85.84M | 95.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.77M | 6.30M | 6.13M | 5.89M | 9.64M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 200.05M | 154.49M | 97.00M | 140.18M | 123.79M |
|
|
|||||
| Total Current Liabilities | 200.05M | 154.49M | 97.00M | 140.18M | 123.79M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 78.67M | 79.54M | 81.08M | 65.22M | 18.32M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 100.00K | -- |
| Total Liabilities | 278.72M | 234.03M | 178.08M | 205.50M | 142.11M |
|
|
|||||
| Common Stock & APIC | 4.80B | 4.77B | 4.73B | 4.70B | 4.67B |
| Retained Earnings | -1.91B | -1.70B | -1.53B | -1.39B | -1.25B |
| Treasury Stock & Other | 856.00K | -1.89M | -322.00K | -3.87M | 139.00K |
| Total Common Equity | 2.89B | 3.07B | 3.20B | 3.31B | 3.42B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.89B | 3.07B | 3.20B | 3.31B | 3.42B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.89B | 3.07B | 3.20B | 3.31B | 3.42B |
|
|
|||||